Harvard Drug Group Omega-3 Capsules Recall: Failed Capsule Specifications

Take action

Contact the company & request your remedy

Recalling firmThe Harvard Drug Group LLC7000 Cardinal Pl, N/A · Dublin, OH 43017-1091

No email on file — write to the address above instead.

✎ GovInfoNow plain-language explainer

What happened, in plain English

Harvard Drug Group is recalling Omega-3 Acid Ethyl Esters capsules that failed stability testing for loss on drying. This issue does not pose a safety risk but could affect product quality.

Why it’s dangerous

The capsules failed stability testing for loss on drying, meaning the shell material may degrade over time. This could lead to inconsistent product quality but does not cause immediate safety hazards.

Who’s affected

People who have the specific Omega-3 capsules with NDC 0904-7495-06 and lots N02406 or N02845 are affected. Those using prescription-only capsules for health purposes are most at risk.

How to tell if you have this one

Check for the NDC code 0904-7495-06 and lot numbers N02406 (expiring 10/31/2026) or N02845 (expiring 12/31/2026) on the packaging.

Brand
Harvard Drug Group
Category
Drug

Based on the official FDA remedy

What to do — step by step

Check Product Details
Look for the NDC code 0904-7495-06 and lot numbers N02406 or N02845 on the packaging.

✎ GovInfoNow

Questions people ask

Is this recall dangerous?

No, the recall is for product quality issues only, not safety risks.

What should I do with the recalled capsules?

The official notice does not specify a remedy, so no action is required beyond checking the product details.

How can I confirm if my capsules are recalled?

Check the NDC code 0904-7495-06 and lot numbers N02406 or N02845 on the packaging.

Take action

Contact Harvard Drug Group

We’ve drafted a message you can send Harvard Drug Group to request your refund or repair — edit it as you like.

✉️ Open in email

Subject: Recall D-0493-2026 — Harvard Drug Group Harvard Drug Group

Hello,

I own a Harvard Drug Group that is covered by recall D-0493-2026 from Harvard Drug Group.

I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this?

Thank you.

Similar recalls

From people who’ve dealt with this

Experiences, tips, and questions from readers. Every comment is reviewed before it appears.

No comments yet — be the first to share your experience.

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #D-0493-2026 (April 9, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0493-2026 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.

The Harvard Drug Group LLC recalls Omega-3-Acid, Ethyl Esters, Capsules, USP, 1 gram, 50 capsules (5 x 10 unit dose blister cards) per carton, Rx only,

Lower-risk recall